Category
Peptides
11 articles
September 4, 2026 · 5 min read
Laura Meador Sanction: IRMS Testosterone Finding and Four-Year Ban
An independent arbitrator imposed a four-year sanction on masters weightlifter Laura Meador after USADA presented an IRMS finding consistent with exogenous testosterone.
Peptides
September 4, 2026 · 5 min read
FDA’s September 2026 Peptide Warning-Letter Sweep: What It Means
FDA posted warning letters to several peptide sellers on September 1. The letters focus on intended use, unapproved new drugs, misbranding, and injectable risks.
Peptides
September 1, 2026 · 5 min read
Jara MacDermott Sanction: Testosterone IRMS, TUE Rules, and the Two-Year Ban
USADA imposed a two-year sanction on weightlifter Jara MacDermott after a sample showed canrenone, amphetamine, and testosterone consistent with an external source.
Peptides
September 1, 2026 · 5 min read
Paul Askew Sentencing: How the Rodchenkov Anti-Doping Act Reached a Doping Supplier
Paul Askew received a six-month federal prison sentence after pleading guilty to a conspiracy involving testosterone and a professional track athlete.
Peptides
August 30, 2026 · 5 min read
FDA’s 503B GLP-1 Bulks Proposal: What It Would Exclude
FDA proposed not to place semaglutide, tirzepatide, or liraglutide on the 503B Bulks List. The proposal is not a final ban or drug recall.
Peptides
August 30, 2026 · 5 min read
WHO Starts GLP-1 Implementation Work: What the 2026 Expert Group Will Do
WHO is forming an expert group to develop practical GLP-1 implementation guidance for obesity care, with equity, affordability, and health-system readiness in scope.
Peptides
August 30, 2026 · 5 min read
FDA Reviews Semax, Epitalon, and DSIP-Related Bulk Substances
FDA’s July advisory presentation examined Semax, Epitalon, and Emideltide/DSIP-related bulk substances, emphasizing identity and evidence gaps.
Peptides
August 30, 2026 · 5 min read
FDA Reviews BPC-157, KPV, TB-500, and MOTS-c for the 503A Bulks List
FDA’s July 2026 advisory review examined specific forms and uses of BPC-157, KPV, TB-500, and MOTS-c after their nominations were withdrawn.
Peptides
August 30, 2026 · 5 min read
FDA Revises Generic Peptide Guidance: What the 17 Drafts Cover
FDA published 17 revised draft product-specific guidances for generic peptide development. Here is what they cover—and why they are not approvals.
Peptides
August 29, 2026 · 5 min read
Oral Wegovy in Europe: What EMA’s Tablet Decision Means
EMA’s medicines committee backed an oral Wegovy formulation in May 2026, and the European product record now lists both tablets and pre-filled pens for weight management.
Peptides
August 29, 2026 · 5 min read
FDA’s GLP-1 Import Alert: What Changed for Bulk Drug Substances
FDA revised Import Alert 66-80 on August 21, allowing detention without physical examination of certain GLP-1 bulk drug substances while maintaining a compliance-based Green List.
Peptides
The community
Bodybuilders, veterans, medical professionals & IFBB pros
The articles are the reference — the forum is where it gets real. Cycles, bloodwork, training logs, source talk.